K. H. Pearson

Stable expression and characterisation of a human alpha 7 nicotinic subunit chimera: a tool for functional high-throughput screening.

E. Sher, N. Millar, E. Bell, 2004, European journal of pharmacology.

Identification and Pharmacological Profile of a New Class of Selective Nicotinic Acetylcholine Receptor Potentiators

E. Sher, L. Wallace, L. Broad, 2006, Journal of Pharmacology and Experimental Therapeutics.

Expression and functional characterisation of a human chimeric nicotinic receptor with α6β4 properties

E. Sher, L. Broad, S. Bose, 2003 .

Expression and functional characterisation of a human chimeric nicotinic receptor with alpha6beta4 properties.

E. Sher, L. Broad, S. Bose, 2003, European journal of pharmacology.

5-Hydroxyindole potentiates human α7 nicotinic receptor-mediated responses and enhances acetylcholine-induced glutamate release in cerebellar slices

E. Sher, L. Broad, R. Zwart, 2002, Neuropharmacology.

Physiological roles of neuronal nicotinic receptor subtypes: new insights on the nicotinic modulation of neurotransmitter release, synaptic transmission and plasticity.

T Baldwinson, E. Sher, G. de Filippi, 2003, Current topics in medicinal chemistry.

Allosteric Potentiators of Neuronal Nicotinic Cholinergic Receptors: Potential Treatments for Neurodegenerative Disorders

E. Sher, L. Wallace, L. Broad, 2008 .

PSAB-OFP, a selective alpha 7 nicotinic receptor agonist, is also a potent agonist of the 5-HT3 receptor.

E. Sher, L. Wallace, J. Boot, 2002, European journal of pharmacology.